ELIQUIS is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by E.r. Squibb & Sons, L.l.c.. The primary component is Apixaban.
Product ID | 0003-0894_07ff3e00-b2de-4323-b48e-46e90e682e69 |
NDC | 0003-0894 |
Product Type | Human Prescription Drug |
Proprietary Name | ELIQUIS |
Generic Name | Apixaban |
Dosage Form | Tablet, Film Coated |
Route of Administration | ORAL |
Marketing Start Date | 2012-12-28 |
Marketing Category | NDA / NDA |
Application Number | NDA202155 |
Labeler Name | E.R. Squibb & Sons, L.L.C. |
Substance Name | APIXABAN |
Active Ingredient Strength | 5 mg/1 |
Pharm Classes | Factor Xa Inhibitor [EPC],Factor Xa Inhibitors [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |
Marketing Start Date | 2012-12-28 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA202155 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2017-06-01 |
Marketing Category | NDA |
Application Number | NDA202155 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2012-12-28 |
Marketing Category | NDA |
Application Number | NDA202155 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2012-12-28 |
Marketing Category | NDA |
Application Number | NDA202155 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2012-12-28 |
Marketing Category | NDA |
Application Number | NDA202155 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2012-12-28 |
Marketing End Date | 2017-06-01 |
Ingredient | Strength |
---|---|
APIXABAN | 5 mg/1 |
SPL SET ID: | e9481622-7cc6-418a-acb6-c5450daae9b0 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
0003-0893 | ELIQUIS | apixaban |
0003-0894 | ELIQUIS | apixaban |
0003-3764 | ELIQUIS | apixaban |
50090-1436 | ELIQUIS | apixaban |
50090-1437 | ELIQUIS | apixaban |
55154-0612 | ELIQUIS | apixaban |
70518-1861 | ELIQUIS | ELIQUIS |
55154-0613 | ELIQUIS | ELIQUIS |
63629-7747 | ELIQUIS | ELIQUIS |
67296-1673 | ELIQUIS | ELIQUIS |
14445-149 | apixaban | apixaban |
14445-150 | apixaban | apixaban |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
ELIQUIS 85544142 4451882 Live/Registered |
Bristol-Myers Squibb Company 2012-02-16 |
ELIQUIS 78775228 not registered Dead/Abandoned |
Pfizer Inc. 2005-12-16 |
ELIQUIS 77933261 not registered Dead/Abandoned |
Pfizer Inc. 2010-02-11 |
ELIQUIS 77933259 not registered Dead/Abandoned |
BRISTOL-MYERS SQUIBB COMPANY 2010-02-11 |
ELIQUIS 77933257 not registered Dead/Abandoned |
Pfizer Inc. 2010-02-11 |
ELIQUIS 77622324 3674414 Live/Registered |
BRISTOL-MYERS SQUIBB COMPANY 2008-11-26 |
ELIQUIS 76388645 3066277 Dead/Cancelled |
BRISTOL-MYERS SQUIBB COMPANY 2002-02-26 |